Free Trial
NASDAQ:FNX

First Trust Mid Cap Core AlphaDEX Fund (FNX) Price, Holdings, & News

First Trust Mid Cap Core AlphaDEX Fund logo
$116.38 +1.53 (+1.33%)
As of 03:59 PM Eastern

About First Trust Mid Cap Core AlphaDEX Fund (NASDAQ:FNX)

Key Stats

Today's Range
$114.64
$117.11
50-Day Range
$101.49
$114.85
52-Week Range
$93.19
$127.98
Volume
30,937 shs
Average Volume
33,178 shs
Market Capitalization
$1.14 billion
Assets Under Management
$1.13 billion
Dividend Yield
1.26%
Net Expense Ratio
0.58%
Aggregate Rating
Moderate Buy

ETF Overview

First Trust Mid Cap Core AlphaDEX Fund Expenses

TypeFNXMid Cap ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.50%0.36%0.56%0.54%0.53%
Other Expenses0.08%0.47%0.56%0.52%0.56%
Total Expense0.58%0.51%0.76%0.74%0.73%
Fee Waiver0.00%-0.73%-0.66%-0.50%-0.63%
Net Expense0.58%0.38%0.63%0.63%0.60%
Receive FNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust Mid Cap Core AlphaDEX Fund and its competitors with MarketBeat's FREE daily newsletter.

FNX ETF News Headlines

A grave, grave error.
Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the key to unlocking technological breakthroughs we once thought were impossible. And it may just be the only thing capable of bringing America back from the brink of recession – despite Washington’s incompetence and addiction to reckless spending. That’s why Elon Musk, Jeff Bezos, Jensen Huang, and even Bill Gates are pouring billions into the infrastructure behind it.
Analysts Expect FNX To Hit $129
FNY First Trust Mid Cap Growth AlphaDEX® Fund ETF
See More Headlines

FNX ETF - Frequently Asked Questions

First Trust Mid Cap Core AlphaDEX Fund's stock was trading at $115.72 at the start of the year. Since then, FNX stock has increased by 0.5% and is now trading at $116.35.
View the best growth stocks for 2025 here
.

Shares of FNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust Mid Cap Core AlphaDEX Fund investors own include Sunworks (SUNW), Applied DNA Sciences (APDN), Adobe (ADBE), Advanced Micro Devices (AMD), Exact Sciences (EXAS), First Trust Small Cap Core AlphaDEX Fund (FYX) and IDEXX Laboratories (IDXX).

Fund Details

Issuer
First Trust
Fund Name
First Trust Mid Cap Core AlphaDEX Fund
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:FNX
Inception Date
5/8/2007
Fund Manager
Daniel J. Lindquist, Jon Erickson David McGarel, RogerTestin, Stan Ueland, Chris Peterson, Erik Russo
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq AlphaDEX Mid Cap Core Index
Category
Size and Style
Focus
Mid Cap
Development Level
Developed Markets
Region
North America
Number of Holdings
451

Fund Statistics

Assets Under Management
$1.13 billion
Average Daily Volume
$21.39 thousand
Discount/Premium
-0.10%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
First Trust Advisors L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
First Trust Portfolios L.P.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
GTS

Options

Optionable
N/A
Short Interest
13,900 shs

Miscellaneous

Beta
1.10
Creation Unit
50,000
Creation Fee
$1,000.00
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Top 10 FNX Holdings

FNX Sector Exposure

FNX Industry Exposure


This page (NASDAQ:FNX) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners